Daniel Hartnett, associate managing director of the Compliance Risk & Diligence Practice of Kroll, advises on the steps that pharmaceutical companies should take to reduce the risk of dealing with third parties, as they develop a COVID-19 vaccine.
Isabelle Glimcher, a fellow at the NYU Stern Center for Business and Human Rights, recommends six steps that government procurement officials should be taking to prevent workers’ rights abuses by suppliers.